“Woah! It's like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Get 2 Weeks Free

Vyvanse (lisdexamfetamine)

Vyvanse (lisdexamfetamine)

Abstract

General Information Vyvanse (lisdexamfetamine) is a unique extended-release formulation of dextroamphetamine (d-amphetamine). The extended release is achieved through modification of the active molecule dextroamphetamine to form lisdexamfetamine, which is inactive. After Vyvanse is taken, it is rapidly absorbed and distributed to the liver, where it is converted back to the active stimulant, dextroamphetamine. The time to absorb and convert lisdexamfetamine to dextroamphetamine essentially makes Vyvanse an extended-release formulation of dextroamphetamine. Upon activation, Vyvanse is similar to Dexedrine Spansules (dextroamphetamine extendedrelease capsules) and has a duration of action of 8­12 hours. The use of a medication for its approved indications is called its labeled use. In clinical practice, however, physicians often prescribe medications for unlabeled ("off-label") uses when published clinical studies, case reports, or their own clinical experiences support the efficacy and safety of those treatments. Vyvanse is approved by the U.S. Food and Drug Administration (FDA) for treatment of attention-deficit/hyperactivity disorder (ADHD). Physicians, however, may also use it to treat narcolepsy, a condition characterized by daytime somnolence, in which the person periodically falls into a deep sleep during the day. Because Vyvanse is a stimulant, it is a closely regulated controlled substance. The physician must write a new
Loading next page...
Problems Reading this Article? Report Issue Here
/lp/american-psychiatric-publishing-inc-book/vyvanse-lisdexamfetamine-ehKNOWsu0m

You're reading a free preview. Subscribe to read or print the entire article.

And millions more from thousands of peer-reviewed journals, for just $40/month.

Get 2 Weeks Free

To be the best researcher, you need access to the best research

  • With DeepDyve, you can stop worrying about how much articles cost, or if it's too much hassle to order — it's all at your fingertips. Your research is important and deserves the top content.
  • Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.
  • All the latest content is available, no embargo periods.

Stop missing out on the latest updates in your field

  • We’ll send you automatic email updates on the keywords and journals you tell us are most important to you.
  • There is a lot of content out there, so we help you sift through it and stay organized.